How Do Analysts Perceive Crinetics Pharmaceuticals Inc (CRNX)?
Crinetics Pharmaceuticals Inc (CRNX) saw an uptrend of 19.11% in the recent trading with $45.18 being its most recent. The current price level -5.04% lower than the highest price of $47.58 marked by the stock while trading over the past 52-weeks, whereas it is 196.65% higher than the lowest price of $15.23 the company dropped […]
Crinetics Pharmaceuticals Inc (CRNX): The stock medium term indicators say Buy today
Crinetics Pharmaceuticals Inc (CRNX) saw downtrend of -5.65% in the recent trading with $38.21 being its most recent. The current price level -19.69% lower than the highest price of $47.58 marked by the stock while trading over the past 52-weeks, whereas it is 150.89% higher than the lowest price of $15.23 the company dropped to […]
Buy Crinetics Pharmaceuticals Inc (CRNX) today, based on long-term indicators on the stock
Crinetics Pharmaceuticals Inc (CRNX) saw an uptrend of 12.43% in the recent trading with $46.03 being its most recent. The current price level -3.05% lower than the highest price of $47.48 marked by the stock while trading over the past 52-weeks, whereas it is 202.23% higher than the lowest price of $15.23 the company dropped […]
Crinetics Pharmaceuticals Inc (CRNX): The stock’s intermediate-term indicators point to Buy today
Crinetics Pharmaceuticals Inc (CRNX) saw an uptrend of 4.65% in the recent trading with $40.47 being its most recent. The current price level -0.07% lower than the highest price of $40.50 marked by the stock while trading over the past 52-weeks, whereas it is 165.73% higher than the lowest price of $15.23 the company dropped […]
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) gain 5.48% – Is It right time to buy?
Crinetics Pharmaceuticals Inc (CRNX) saw an uptrend of 5.48% in the recent trading with $37.92 being its most recent. The current price level 0.11% lower than the highest price of $37.88 marked by the stock while trading over the past 52-weeks, whereas it is 148.98% higher than the lowest price of $15.23 the company dropped […]